15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
ANALYST CONSENSUS0 ratings
No Rating
Strong Buy00%
Buy00%
Hold00%
Sell00%
Strong Sell00%
Analyst rating coverage is not available for MMS yet.
12-MONTH PRICE TARGET
—
Average analyst target vs $62.95 current
Highest Target—
Average Target—
Lowest Target—
MMS analyst recommendation trends
86420
Jul
Aug
Sep
Oct
Nov
Dec
Strong BuyBuyHoldSellStrong Sell
RATING
JUL
AUG
SEP
OCT
NOV
DEC
Strong Buy
0
0
0
0
0
0
Buy
1
1
1
1
1
1
Hold
0
0
0
0
0
0
Sell
0
0
0
0
0
0
Strong Sell
0
0
0
0
0
0
Total
1
1
1
1
1
1
As of Dec, 1 of 1 firms rate MMS a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
MMS EPS & revenue forecast
EPS · NEXT QUARTER
$2.31
Range $2.28 – $2.33 · 2 analysts · +42% YoY
Next period, 2 analysts expect Maximus Inc to earn $2.31 a share (range $2.28 – $2.33), versus $1.62 a year earlier. Full-year consensus is $8.44, growing to $9.07 the year after.
REVENUE · NEXT QUARTER
$1.3B
Range $1.3B – $1.3B · 2 analysts · -0% YoY
Revenue is expected to reach $1.3B (range $1.3B – $1.3B), -0.1% year-over-year. Full-year consensus is $5.3B, rising to $5.6B next year.
Top analysts covering Maximus Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on MMS.
#1
Brian Gesuale
Raymond James · Rank #189
Buy
$90.00+43.0% to target
Overall win rate
37%
+ Follow
MMS stock forecast FAQ
Who is the most accurate analyst covering MMS?+
Among analysts who currently cover MMS, Brian Gesuale of Raymond James has the strongest overall Quantellect track record (Rank #189). Their current call is Buy with a $90.00 target.
What is Maximus Inc's projected EPS for next quarter?+
The consensus estimate is $2.31 per share (range $2.28 – $2.33) across 2 analysts. Full-year EPS is projected at $8.44, rising to $9.07 the following year.
How much revenue is Maximus Inc expected to report next quarter?+
Consensus revenue is $1.3B (range $1.3B – $1.3B). Full-year revenue is projected at $5.3B, growing to $5.6B next year.
Have analysts been upgrading or downgrading MMS lately?+
As of Dec, 1 of 1 firms rate MMS a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their MMS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
